Dapagliflozin Polpharma

Dapagliflozin Polpharma is an oral medication used to manage blood sugar levels in adults with type 2 diabetes. It belongs to a class of drugs known as SGLT2 inhibitors, which help the kidneys remove excess glucose from the body. This medication is manufactured by Zaklady Farmaceutyczne Polpharma S.A. in the EU.

Dapagliflozin Polpharma is primarily used to control blood sugar levels in adults with type 2 diabetes. It works by inhibiting the SGLT2 protein in the kidneys, which helps to remove excess glucose through urination. This medication is often used alongside diet and exercise to manage diabetes effectively. People may wonder, 'What is Dapagliflozin used for?' and the answer is that it is designed to improve glycemic control in diabetic patients.

Common effects of Dapagliflozin Polpharma may include increased urination, which is a direct result of its mechanism of action. Some users might experience symptoms such as thirst, dry mouth, or urinary tract infections. It is important to stay hydrated while taking this medication to help mitigate these effects.

Before using Dapagliflozin Polpharma, it is crucial to inform your healthcare provider about any existing medical conditions, especially kidney problems or a history of urinary tract infections. This medication should be used with caution in patients with severe kidney impairment. Always follow the advice of a healthcare professional regarding the use of this medication.

Dapagliflozin Polpharma may interact with certain medications, including insulin and other diabetes drugs. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, alcohol consumption should be moderated, as it can affect blood sugar levels and overall health.